Biogen Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Biogen Inc inventory turnover ratio, the Biogen Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.13 in the first quarter 2026, yet the ratio remained below the average, as BIIB's market remain challenging.Average inventory processing period, for the Biogen Inc in Mar 31 2026 quarter, has decreased to 323 days, compare to 338 days, in the Dec 31 2025 quarter.

Within Healthcare sector 300 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 478 in the fourth quarter 2025, to 649.

BIIB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biogen Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BIIB Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-14.29 %	-11.88 %	-10.52 %	-9.25 %	-9.65 %
Y / Y Cost of Sales Growth	5.04 %	-15.08 %	5.59 %	10.81 %	16.06 %
Inventory Turnover Ratio (TTM)	1.13	1.08	1.08	1.04	0.99
BIIB's Total Ranking	# 649	# 478	# 485	# 485	# 485
Average inventory processing period	322	339	338	352	370
Seq. Inventory Growth	-10.11 %	-1.87 %	-2.85 %	0.02 %	-7.58 %
Seq. Cost of Sales Growth	33.4 %	-26.53 %	11.47 %	-3.86 %	7.85 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 21
Healthcare Sector	# 301
Overall Market	# 649

Inventory Turnover Ratio Statistics
High	Average	Low
2.57	1.63	-1.51
(March 31, 2012)		(Sep 30 2017)

BIIB Company Profile >> Back to BIIB Efficiency Comparisons >> Compare BIIB Inventory Turnover Ratio to its Competitors

Financial Statements
Biogen Inc 's Inventories	$ 1,949 Millions	Visit BIIB's Balance sheet
Biogen Inc 's Cost of Revenues TTM	$ 2,436 Millions	Visit BIIB's Income Statement
What are BIIB's Sales?		Visit BIIB's Sales by Segment

Other Inventory Turnover Ratios
Biogen Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BIIB's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BIIB's Competitors
Inventory Turnover Ratio for BIIB's Suppliers
Inventory Turnover Ratio for BIIB's Customers

You may also want to know
BIIB's Sales Growth Rates	BIIB's Pe Price to earnings ratio	BIIB's Receivables Turnover Ratio	BIIB's Stock Quote
BIIB's Net Income Growth Rates	BIIB's Ps Price to Sales ratio	BIIB's Sales per Employee	BIIB's Asset Turnover Ratio
BIIB's Net Margin	BIIB's Pb Price to Book ratio	BIIB's Financial Strength Ratios	BIIB's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Exelixis Inc	3.41	$ 84.478 Millions	$ 25 Millions
Baxter International Inc	3.37	$ 7,911.000 Millions	$ 2,348 Millions
Gilead Sciences Inc	3.36	$ 6,139.000 Millions	$ 1,825 Millions
Maravai Lifesciences Holdings Inc	3.33	$ 143.875 Millions	$ 43 Millions
Intelligent Bio Solutions Inc	3.31	$ 2.064 Millions	$ 1 Millions
Agilent Technologies inc	3.29	$ 3,418.000 Millions	$ 1,038 Millions
Cadre Holdings inc	3.28	$ 372.000 Millions	$ 113 Millions
Solventum Corporation	3.23	$ 3,363.000 Millions	$ 1,042 Millions
Biofrontera Inc	3.22	$ 8.867 Millions	$ 3 Millions
10x Genomics Inc	3.21	$ 193.000 Millions	$ 60 Millions
Iovance Biotherapeutics inc	3.14	$ 165.941 Millions	$ 53 Millions
Lftd Partners Inc	3.12	$ 28.258 Millions	$ 9 Millions
Prestige Consumer Healthcare Inc	3.11	$ 493.000 Millions	$ 159 Millions
Beyond Air Inc	3.07	$ 6.521 Millions	$ 2 Millions
Bausch Health Companies Inc	3.07	$ 2,987.000 Millions	$ 974 Millions
Indivior Pharmaceuticals Inc	3.03	$ 242.000 Millions	$ 80 Millions
Amneal Pharmaceuticals Inc	3.02	$ 1,868.000 Millions	$ 618 Millions
Logicmark Inc	3.01	$ 3.826 Millions	$ 1 Millions
Mettler toledo International Inc	3.01	$ 1,189.678 Millions	$ 395 Millions
Revvity Inc	3.00	$ 1,151.379 Millions	$ 384 Millions
Cannapharmarx Inc	2.98	$ 2.921 Millions	$ 1 Millions
Becton Dickinson And Company	2.97	$ 11,368.000 Millions	$ 3,821 Millions
Dexcom Inc	2.97	$ 1,854.000 Millions	$ 624 Millions
Msa Safety Inc	2.93	$ 1,020.000 Millions	$ 349 Millions
Nexgel Inc	2.92	$ 6.000 Millions	$ 2 Millions
Abbott Laboratories	2.91	$ 19,741.000 Millions	$ 6,785 Millions
Zai Lab Limited	2.91	$ 128.112 Millions	$ 44 Millions
Mimedx Group Inc	2.87	$ 74.000 Millions	$ 26 Millions
Dentsply Sirona Inc	2.82	$ 1,880.000 Millions	$ 666 Millions
Catalyst Pharmaceuticals Inc	2.82	$ 83.817 Millions	$ 30 Millions

Date modified: 2026-08-29T17:18:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.